Related Experiment Video
Updated: Apr 21, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Immunotherapy: Treatment of aggressive lymphomas with anti-CD19 CAR T cells
Christopher A Klebanoff1, Tori N Yamamoto1, Nicholas P Restifo1
1Center for Cancer Research, Surgery Branch, Immunotherapy Section, 10 Center Drive, Building 10/CRC, Room 3 West-5816, Bethesda, MA 20892, USA.
No abstract available in PubMed .
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...